Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 10/10/2024 | $98.00 → $105.00 | Sector Perform → Outperform | RBC Capital Mkts | |
| 10/1/2024 | $37.00 | Buy → Neutral | Citigroup | |
| 9/27/2024 | $37.00 | Buy → Neutral | BofA Securities | |
| 8/23/2024 | $38.00 → $42.00 | Overweight | JP Morgan | |
| 8/21/2024 | $92.00 → $94.00 | Perform | Oppenheimer | |
| 8/19/2024 | $37.00 → $37.00 | Overweight → Equal-Weight | Morgan Stanley | |
| 8/15/2024 | $76.00 → $90.00 | Sell → Neutral | UBS | |
| 8/14/2024 | $100.00 → $85.00 | Buy → Hold | Stifel |
New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance for its new InPen™ app featuring missed meal dose detection, paving the way for the launch of its Smart MDI system with the Simplera™ continuous glucose monitor (CGM). The company's Smart MDI system combines its InPen™ smart insulin pen with its newest Simplera™ CGM — the company's first disposable, all-in-one CGM that's half the size of previous
Delivering on commitments, executing ahead of expectations, and raising guidance Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation GALWAY, Ireland, Nov. 19, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October 25, 2024. Key Highlights Revenue of $8.4 billion increased 5.3% as reported and 5.0% organicGAAP diluted earnings per share (EPS) of $0.99; non-GAAP diluted EPS of $1.26Company raises FY25 organic revenue growth and EPS guidanceFinancial ResultsMedtronic reported Q2 worldwide revenue of $8.403 billion, an
NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its third quarter 2024 financial results and provided a business update. "The Orchestra BioMed team is focused on execution of the BACKBEAT global pivotal study alongside our strategic partner, Medtronic. We are excited about the enthusiasm we have seen from the clinical community for the potential of AVIM therapy to provide these typically older, higher risk hypertension patients with a potent, programmable, always on t
3 - HP INC (0000047217) (Issuer)
4 - HP INC (0000047217) (Issuer)
4 - HP INC (0000047217) (Issuer)
Delivering on commitments, executing ahead of expectations, and raising guidance Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation GALWAY, Ireland, Nov. 19, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October 25, 2024. Key Highlights Revenue of $8.4 billion increased 5.3% as reported and 5.0% organicGAAP diluted earnings per share (EPS) of $0.99; non-GAAP diluted EPS of $1.26Company raises FY25 organic revenue growth and EPS guidanceFinancial ResultsMedtronic reported Q2 worldwide revenue of $8.403 billion, an
PALO ALTO, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- HP Inc. (NYSE:HPQ) will present a live audio webcast of a conference call to review financial results for the fourth fiscal quarter and fiscal year ended October 31, 2024 on Tuesday, Nov 26, 2024 at 5:30 p.m. ET / 2:30 p.m. PT. The webcast will be available at www.hp.com/investor/2024Q4Webcast. A replay of the audio webcast will be available at the same website shortly after the call and will remain available for approximately one year. About HP Inc. HP Inc. (NYSE:HPQ) is a global technology leader and creator of solutions that enable people to bring their ideas to life and connect to the things that matter most. Operating in
PALO ALTO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- HP (NYSE:HPQ) Third quarter GAAP diluted net earnings per share ("EPS") of $0.65, within the previously provided outlook of $0.63 to $0.77 per shareThird quarter non-GAAP diluted net EPS of $0.83, within the previously provided outlook of $0.78 to $0.92 per shareThird quarter net revenue of $13.5 billion, up 2.4% from the prior-year periodThird quarter net cash provided by operating activities of $1.4 billion, free cash flow of $1.3 billionThird quarter returned $0.9 billion to shareholders in the form of share repurchases and dividendsShare repurchase authorization increased to $10.0 billion HP Inc.'s fiscal 2024 third quarter financi
RBC Capital Mkts upgraded Medtronic from Sector Perform to Outperform and set a new price target of $105.00 from $98.00 previously
Citigroup downgraded HP Inc. from Buy to Neutral and set a new price target of $37.00
BofA Securities downgraded HP Inc. from Buy to Neutral and set a new price target of $37.00
SC 13G/A - HP INC (0000047217) (Subject)
SC 13G/A - HP INC (0000047217) (Subject)
SC 13G - HP INC (0000047217) (Subject)
8-K - Medtronic plc (0001613103) (Filer)
144 - Medtronic plc (0001613103) (Subject)
144 - Medtronic plc (0001613103) (Subject)
News Highlights: Unleashes flexibility and style for freelancers and creators with HP's first 2-in-1 next-gen AI PC, the HP OmniBook Ultra FlipIntroduces the first HP EliteBook X, the world's most powerful next-gen AI business notebook1 for tech experts and business consultants, with up to an industry-leading 55 TOPS of NPU performance2Unveils innovative memory architecture that revolutionizes on-device AI, delivering lightning-fast performance for the most complex workflowsRedefines workspaces with the industry's broadest portfolio of AI-enabled multi-camera capable video conferencing solutions3Empowers on-demand performance for data scientists and AI developers with Z by HP Boost, the wor
News Highlights: HP announces the only AI platform for workstations with built-in generative AI trust for large language model (LLM) development2 to detect and correct bias in models in Z by HP AI StudioIntroducing the first HP OmniBook Ultra, the world's highest performance AI PC1 with up to an industry-leading 55 TOPS of NPU performance3Safely and securely use AI with Wolf Security on the HP OmniBook Ultra, the world's most secure consumer next gen AI PC4Explore endless possibilities with the latest AI-powered apps for productivity and content creation from Beautiful.ai, Loccus.ai, Luminar Neo, Omnibridge, Polymer, and Virtual Sapiens PALO ALTO, Calif., July 15, 2024 (GLOBE NEWSWIR
PALO ALTO, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- HP Inc. (NYSE:HPQ) today announced that Karen Parkhill will join the company as Chief Financial Officer on August 5, 2024. Tim Brown, who has been serving as interim Chief Financial Officer, will return to his role as the head of Print Finance. A world-class finance leader, Parkhill, has spent the past 13 years serving as the Chief Financial Officer for well-established, publicly traded companies. Parkhill joins HP from Medtronic plc, a leading global healthcare technology company with more than 95,000 employees across 150 countries, where she served as Executive Vice President and Chief Financial Officer since 2016. "Karen
Abbott Laboratories (NYSE:ABT) CEO Robert Ford said the company will use a mix of TV advertisements and guerilla marketing to promote the U.S. launch of Lingo, its glucose monitoring device. This device targets consumers without diabetes, aiming to personalize health data and enhance understanding of their health metrics. Also Read: Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits. Ford projected that Lingo could become a multi-billion-dollar product, although it is still in its nascent stage. Lingo, an over-the-counter device, is scheduled to launch this year alongside Libre Rio, which received FDA clearance last month. Abbott’s consumer bi
As of July 18, 2024, three stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here's the latest list of major overbought players in this sector. IBM Common Stock (NYSE:IBM) International Business Machines is expected to repor
RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Sector Perform and maintains $92 price target.